Clinical Trials Logo
  1. Home
  2. Pharyngitis
  3. NCT02252419
  4. Details
NCT02252419 Clinical Trial

Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat

Pharyngitis Clinical Trial

Official title:
Combined Effect of Preoperative Dexamethasone and Intraoperative Paracetamol on Postoperative Sore Throat for Patients Undergoing Urologic Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT02252419
Other study ID # SoreThroatParacetamol
Secondary ID
Status Not yet recruiting
Phase N/A
First received September 26, 2014
Last updated October 16, 2014
Start date October 2014
Est. completion date March 2015

Study information
Verified date September 2014
Source Seoul National University Hospital
Contact Hyun-Chang Kim, MD
Phone 82-10-2886-2876
Email onidori1979@gmail.com
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The investigators want to evaluate the efficacy of the dexamethasone and paracetamol for the prevention of postoperative sore throat.

Description:

The postoperative sore throat is a common complication after the general anesthesia which decreases the quality of life. Dexamethasone is known to effective for the prevention of postoperative sore throat. The combined effect of the dexamethasone and paracetamol for postoperative sore throat, however, is not investigated.

The investigators want to evaluate the efficacy of the dexamethasone and paracetamol for the prevention of postoperative sore throat.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 242
Est. completion date March 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender Both
Age group 19 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients scheduled for urologic surgery under general anesthesia

- ASA I-III

Exclusion Criteria:

- Patients with recent sore throat

- Patients with neck surgery

- Patients with anticipated difficult airway

- Patients with Mallampati grade 3

- Patients with severe cardiovascular or pulmonary disease

- Patients with allergic history to dexamethasone or paracetamol

- Patients with liver function disorder

- Patients with liver disease

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Intervention

Drug:
• Dexamethasone
Dexamethasone will be administered.
• Paracetamol
Paracetamol will be administered.

Locations
Country Name City State
Korea, Republic of Seolu National University of Hospital Seoul

Sponsors (1)
Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Postoperative sore throat Postoperative sore throat after 1 hour postoperatively will be measured (0:none, 1:mild, 2:moderate, 3:severe) 1 hour postoperatively No
Secondary Postoperative sore throat degree Postoperative sore throat degree after 0, 1, 6, 24 hour postoperatively will be measured (11 points, 0:none, 10:worst imaginable). 0, 1, 6, 24 hour postoperatively No
Secondary Postoperative pain Postoperative pain after 0, 1, 6, 24 hour postoperatively will be measured (11 points, 0:none, 10:worst imaginable). 0, 1, 6, 24 hour postoperatively No
Secondary Nausea Nausea will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Vomiting Vomiting will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Somnolence Somnolence will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Shivering Shivering will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Headache Headache will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Hoarseness Hoarseness will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Dysphagia Dysphagia will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Analgesics Analgesics usage will be measured at 0, 1, 6 and 24 hour postoperatively. 0, 1, 6, 24 hour postoperatively No
Secondary Postoperative sore throat Postoperative sore throat after 0, 6, 24 hour postoperatively will be measured (0:none, 1:mild, 2:moderate, 3:severe) 0, 6, 24 hour postoperatively No
See also
  Status Clinical Trial Phase
Completed NCT01453400 - Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain Phase 3
Completed NCT04016051 - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections Phase 3
Recruiting NCT01681667 - Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain Phase 4
Completed NCT00527852 - Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis N/A
Completed NCT02178293 - Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride Phase 4
Active, not recruiting NCT05127161 - Broad Implementation of Outpatient Stewardship N/A
Withdrawn NCT02535962 - Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Phase 2
Completed NCT00798018 - Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena N/A
Completed NCT00535093 - An Assessment of Rapid Streptococcal Tests in Community Clinics in Israel N/A
Completed NCT00148499 - Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis Phase 3
Completed NCT00095368 - APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat Phase 3
Recruiting NCT06027593 - Using Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship Interventions N/A
Recruiting NCT03720301 - The Use of Osteopathic Medical Manipulation to Decrease the Incidence and Severity of Post-Operative Sore Throat N/A
Completed NCT01361399 - Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold Phase 3
Completed NCT01398696 - Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour Phase 4
Completed NCT01048866 - A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis Phase 3
Completed NCT01049334 - A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis Phase 3
Completed NCT00547391 - Recurrent Throat Infections and Tonsillectomy Phase 4
Completed NCT00242281 - APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat Phase 3
Completed NCT01465009 - Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold Phase 4